Menu

Speaking of Cancer Research

Notable quotes from this year’s annual meeting of the American Association for Cancer Research

Apr 5, 2017
Jef Akst

JEF AKST

“This is no time to undercut progress, for God’s sake. It’s no time to let up. It’s time to double down. It’s time we deliver on the promise of science and technology to extend and improve lives.”

—Former US Vice President Joe Biden

 

“Funding for cancer research isn’t something you can turn on and off like a faucet.”

Nancy Davidson, AACR President

 

“There has been a revolution in cancer research in the past decade. If I were to summarize that revolution in one sentence it would be: cancer results from the sequential accumulation of genomic alterations. . . . The challenge for all of us here to today is to achieve the next revolution, and that is to dramatically reduce deaths from cancer.”

Bert Vogelstein, Johns Hopkins Medicine

 

“At first blush, the problem of [cancer drug] resistance seems insurmountable. It’s multifactorial and heterogeneous. There can be multiple resistance mechanisms operating in a particular patient.”

Levi Garraway, Eli Lilly

 

“Early detection doesn’t have to be very early. . . . It takes years, perhaps decades, for a [malignancy] to evolve into a widely metastatic lesion, offering a huge window of opportunity to detect those cancers and intervene in the process.”

Vogelstein

 

“In our fight against cancer, we have to be unwilling to postpone for even a second. . . . Let’s keep it going, folks. This is no time to stop the momentum.”

Biden

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.